22607720

Wang F

2012

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats.

22607767

Campagnoli C

2012

Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.

22607890

Shi D

2012

Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.

22607892

Svendsen PF

2012

Adipose expression of adipocytokines in women with polycystic ovary syndrome.

22608319

Will MA

2012

Metformin: direct inhibition of rat ovarian theca-interstitial cell proliferation.

22610962

Franks S

2012

Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction.

22611175

ESHRE Capri Workshop Group.

2012

Health and fertility in World Health Organization group 2 anovulatory women.

22612517

Genazzani AD

2012

Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.

22612600

Palomba S

2012

Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study.

22617121

Ouandaogo ZG

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo and in vitro oocyte maturation.

22617579

Roth LW

2012

Altering hirsutism through ovulation induction in women with polycystic ovary syndrome.

22621463

Sara L

2012

Pharmacological reactivity of resistance vessels in a rat PCOS model - vascular effects of parallel vitamin D? treatment.

22621680

Bayrak T

2012

Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.

22621829

Zheng X

2012

Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome.

22633255

Veltman-Verhulst SM

2012

High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice.

22634902

Sijanovi? S

2012

Role of laparoscopic surgery in treatment of infertility.

22635019

Venturella R

2012

[Assessment of the modification of the clinical, endocrinal and metabolical profile of patients with PCOS syndrome treated with myo-inositol].

22635021

Nahid L

2012

Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome.

22639397

Gao L

2012

Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials.

22639834

Costello MF

2012

The treatment of infertility in polycystic ovary syndrome: a brief update.

22640495

Anderson RA

2012

What does anti-M?llerian hormone tell you about ovarian function?

22641183

Joham AE

2012

Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.

22643321

Raissouni N

2012

Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome.

22646322

Grynnerup AG

2012

The role of anti-M?llerian hormone in female fertility and infertility - an overview.

22648217

Kim GK

2012

Post-adolescent acne in women: more common and more clinical considerations.

22648908

Catteau-Jonard S

2012

Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?

22650028

Liu J

2012

[The role of oxidative stress in the pathogenesis of polycystic ovary syndrome].

22654211

Ma RJ

2011

Combination of acupuncture and chinese medicinal herbs in treating model rats with polycystic ovary syndrome.

22654525

Golbahar J

2012

Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain.

22655062

Amalfi S

2012

Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure.

22658347

Gremeau AS

2012

In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles.

22661293

Witchel SF

2012

Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

22662009

Cebeci F

2012

Insulin resistance in women with hirsutism.

22668987

Brown RE

2012

Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).

22672538

Purwana IN

2013

Successful pregnancy after the treatment of primary amenorrhea in a patient with non-classical congenital adrenal hyperplasia.

22672648

Yin Q

2013

Apolipoprotein B/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome.

22673295

Li W

2012

Dysregulation of glucose metabolism even in Chinese PCOS women with normal glucose tolerance.

22673409

Woo HY

2012

Differences of the association of anti-M?llerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome.

22674204

Zhang J

2012

Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.

22678803

Lin Y

2012

[Polymorphisms of FEM1A gene in patients with polycystic ovary syndrome].

22679042

Abdo S

2011

Hair, sweat and tears.

22686091

Wang YH

2012

[Effects of compound ganshao paste on the levels of sex hormones and hepatic transaminases in polycystic ovarian syndrome rat model].

22686097

Sun JL

2012

[Exploration of the causes of polycystic ovary syndrome and its therapeutic mechanisms by acupuncture].

22693172

Eilertsen TB

2012

Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

22693174

Chen MJ

2012

Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.

22695532

Wang R

2012

Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis.

22696324

Farquhar C

2012

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

22698921

Gambineri A

2012

Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.

22698930

Feigenbaum SL

2012

Prevalence of cervical insufficiency in polycystic ovarian syndrome.

22699877

Zhang CW

2012

Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women.

22700441

Nugent BM

2012

Hormonal programming across the lifespan.

22702394

Harmanci A

2013

Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.

22703625

Bayram F

2012

Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.

22703626

Li RH

2012

Management of anovulatory infertility.

22704100

Panicker JN

2012

The possible role of opiates in women with chronic urinary retention: observations from a prospective clinical study.

22707671

Chan Y

2012

Note of clarification of data in the meta-analysis of methylenetetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.

22709979

Codner E

2012

Female reproduction and type 1 diabetes: from mechanisms to clinical findings.

22712547

Phelan N

2013

Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance.

22713099

Ilie IR

2012

Ethinylestradiol30?g-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?

22714408

Chiang CW

2012

Ultraconserved elements in the human genome: association and transmission analyses of highly constrained single-nucleotide polymorphisms.

22718099

Alanbay I

2012

A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity?

22719052

Ortega I

2012

Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway.

22723319

Jones MR

2012

Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility.

22723725

Okoroafor UC

2012

Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome.

22724514

Villa P

2013

Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence.

22724574

Echibur? B

2012

CAG repeat polymorphism of androgen receptor gene and X-chromosome inactivation in daughters of women with polycystic ovary syndrome (PCOS): relationship with endocrine and metabolic parameters.

22727793

Imbar T

2012

Altered endothelin expression in granulosa-lutein cells of women with polycystic ovary syndrome.

22727921

Gateva AT

2012

Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome.

22729136

Casadei L

2012

Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.

22729915

Tang ST

2012

Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis.

22730726

Minegishi T

2012

[Endocrine disease:progress in diagnosis and treatment. Topics: II. Progress in treatment; 2. Assessment and management of dysfunction of pituitary-gonad axis].

22733850

Battaglia C

2012

Two- and three-dimensional sonographic and color Doppler techniques for diagnosis of polycystic ovary syndrome. The stromal/ovarian volume ratio as a new diagnostic criterion.

22737168

Wongwananuruk T

2012

The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome.

22737516

Behradmanesh S

2011

Effect of metformin on serum ferritin level in women with polycystic ovary syndrome.

22738153

Knebel B

2012

Genetic variants in central metabolic genes influence some but not all relations of inflammatory markers in a collective with polycystic ovary syndrome.

22740491

Bazarganipour F

2012

Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire.

22744623

Szydlarska D

2012

Measuring salivary androgens as a useful tool in the diagnosis of polycystic ovary syndrome.

22745860

Shin HY

2011

Adiponectin in women with polycystic ovary syndrome.

22748101

Agarwal A

2012

The effects of oxidative stress on female reproduction: a review.

22748844

Li R

2012

Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system.

22749225

Jayaprakasan K

2012

Prediction of in?vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women.

22752961

Gonz?lez F

2012

Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.

22764561

Connor EL

2012

Adolescent polycystic ovary syndrome.

22767467

Lim SS

2012

Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis.

22767635

Morgan CL

2012

Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.

22768457

Mehrabian F

2012

The laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome; a randomized controlled trial.

22771030

Carmina E

2012

Does the level of serum antim?llerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging?

22772454

Polzikov M

2012

Overexpression of ribosomal RNA in cumulus cells of patients with polycystic ovary syndrome.

22772786

Palihawadana TS

2012

Aetiology of infertility among females seeking treatment at a tertiary care hospital in Sri Lanka.

22774210

Strauss JF 3rd

2012

Persistence pays off for PCOS gene prospectors.

22774396

Nordio M

2012

The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.

22775449

Sprung VS

2013

Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies.

22777527

Yildiz BO

2012

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.

22778207

Khan AT

2010

Fowler's syndrome and pregnancy.

22778212

Hirsch A

2012

Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain.

22778733

Hern?ndez-Yero A

2012

Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemia.

22779343

Krysiak R

2012

[Current opinions on the etiology and pathophysiology of hirsutism].

22780885

Pal L

2012

Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome.

22781076

Rackow BW

2012

Polycystic ovary syndrome in adolescents.

22781109

Yu R

2012

[Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].